158 related articles for article (PubMed ID: 21327404)
21. Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim.
Seddiq M; Gadgeel M; Persaud Y; Lafferty J; Savaşan S
Br J Haematol; 2020 Aug; 190(4):e239-e242. PubMed ID: 32515038
[No Abstract] [Full Text] [Related]
22. Persistent thrombocytopenia post auto-SCT for AML treated with romiplostim in a patient with HIV.
Gangatharan SA; Cooney JP
Bone Marrow Transplant; 2011 Sep; 46(9):1280-1. PubMed ID: 21151181
[No Abstract] [Full Text] [Related]
23. Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.
Cantoni N; Heizmann M; Bargetzi M
Br J Haematol; 2012 Jun; 157(5):639-41. PubMed ID: 22329466
[No Abstract] [Full Text] [Related]
24. Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.
Gangireddy VG; Coleman TA; Nabh A; Sridhar S
Dig Dis Sci; 2012 Sep; 57(9):2466-72. PubMed ID: 22828806
[No Abstract] [Full Text] [Related]
25. Romiplostim.
Kuter DJ
Cancer Treat Res; 2011; 157():267-88. PubMed ID: 21052962
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.
Hartranft ME; Clemmons AB; DeRemer DL; Kota V
J Oncol Pharm Pract; 2017 Jan; 23(1):10-17. PubMed ID: 26471738
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Jang JH; Tomiyama Y; Miyazaki K; Nagafuji K; Usuki K; Uoshima N; Fujisaki T; Kosugi H; Matsumura I; Sasaki K; Kizaki M; Sawa M; Hidaka M; Kobayashi N; Ichikawa S; Yonemura Y; Enokitani K; Matsuda A; Ozawa K; Mitani K; Lee JW; Nakao S
Br J Haematol; 2021 Jan; 192(1):190-199. PubMed ID: 33152120
[TBL] [Abstract][Full Text] [Related]
28. Romiplostim: new drug. Thrombocytopenic purpura: for selected patients, with close monitoring.
Prescrire Int; 2009 Dec; 18(104):246. PubMed ID: 20020571
[No Abstract] [Full Text] [Related]
29. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist.
LaMoreaux B; Barbar-Smiley F; Ardoin S; Madhoun H
Semin Arthritis Rheum; 2016 Feb; 45(4):e10-2. PubMed ID: 26329147
[TBL] [Abstract][Full Text] [Related]
30. Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy.
Kantarjian HM; Giles FJ; Greenberg PL; Paquette RL; Wang ES; Gabrilove JL; Garcia-Manero G; Hu K; Franklin JL; Berger DP
Blood; 2010 Oct; 116(17):3163-70. PubMed ID: 20631375
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus.
Alkaabi JK; Alkindi S; Riyami NA; Zia F; Balla LM; Balla SM
Lupus; 2012 Dec; 21(14):1571-4. PubMed ID: 23161577
[TBL] [Abstract][Full Text] [Related]
32. Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.
Platzbecker U; Sekeres MA; Kantarjian H; Giagounidis A; Mufti GJ; Jia C; Yang AS; Fenaux P
Leukemia; 2014 Dec; 28(12):2418-21. PubMed ID: 25179731
[No Abstract] [Full Text] [Related]
33. Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.
Minowa K; Arai K; Kasahara M; Sakamoto S; Shimizu H; Nakano N; Ito R; Obayashi N; Nakazawa A; Ishiguro A
Pediatr Transplant; 2014 Sep; 18(6):E212-5. PubMed ID: 25041553
[TBL] [Abstract][Full Text] [Related]
34. Infection-related transient loss of response and other early side effects in chronic ITP during treatment with thrombopoietin mimetics.
Meyer O; Salama A
Onkologie; 2011; 34(1-2):10-3. PubMed ID: 21346379
[TBL] [Abstract][Full Text] [Related]
35. Romiplostim for the treatment of primary immune thrombocytopenia.
Janssens A
Expert Rev Hematol; 2012 Apr; 5(2):133-44. PubMed ID: 22475281
[TBL] [Abstract][Full Text] [Related]
36. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
37. Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
Zimrin A; Chumsri S
Ann Hematol; 2013 Aug; 92(8):1145-6. PubMed ID: 23328792
[No Abstract] [Full Text] [Related]
38. The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab.
Gonzalez-Nieto JA; Martin-Suarez I; Quattrino S; Ortiz-Lopez E; Muñoz-Beamud FR; Colchero-Fernández J; Alcoucer-Diaz MR
Lupus; 2011 Oct; 20(12):1321-3. PubMed ID: 21719526
[TBL] [Abstract][Full Text] [Related]
39. Erythematous rash following romiplostim administration in a patient with autoimmune lymphoproliferative syndrome.
Biondo L; Bodge M; Paul SR
Ann Pharmacother; 2013 Jan; 47(1):e7. PubMed ID: 23300150
[TBL] [Abstract][Full Text] [Related]
40. Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
Soff GA; Miao Y; Bendheim G; Batista J; Mones JV; Parameswaran R; Wilkins CR; Devlin SM; Abou-Alfa GK; Cercek A; Kemeny NE; Sarasohn DM; Mantha S
J Clin Oncol; 2019 Nov; 37(31):2892-2898. PubMed ID: 31545663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
